CATSPER3 | Cation channel, sperm associated 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CATSPER4 | Cation channel, sperm associated 4 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
CATSPERB | Catsper channel auxiliary subunit beta | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CATSPERD | Catsper channel auxiliary subunit delta | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CATSPERG | Catsper channel auxiliary subunit gamma | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV3 | Caveolin 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CCDC109B | Coiled-coil domain containing 109B | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNA7 | Cholinergic receptor, nicotinic, alpha 7 (neuronal) | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CHRNB1 | Cholinergic receptor, nicotinic, beta 1 (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CHRNB2 | Cholinergic receptor, nicotinic, beta 2 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CHRND | Cholinergic receptor, nicotinic, delta (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CHRNE | Cholinergic receptor, nicotinic, epsilon (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CHRNG | Cholinergic receptor, nicotinic, gamma (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCN1 | Chloride channel, voltage-sensitive 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN15 | Claudin 15 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN19 | Claudin 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLDN22 | Claudin 22 | Predicted membrane proteins Transporters
| | | | | Not detected |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDND1 | Claudin domain containing 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC2 | Chloride intracellular channel 2 | Disease related genes Potential drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CLIC4 | Chloride intracellular channel 4 | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC5 | Chloride intracellular channel 5 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CLNS1A | Chloride channel, nucleotide-sensitive, 1A | Cytoskeleton related proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CLRN2 | Clarin 2 | Predicted membrane proteins Transporters
| | | | | Not detected |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CMTM7 | CKLF-like MARVEL transmembrane domain containing 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CNGA1 | Cyclic nucleotide gated channel alpha 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CNGA3 | Cyclic nucleotide gated channel alpha 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNNM3 | Cyclin and CBS domain divalent metal cation transport mediator 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |